What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis

2020/05/20 by Janni Leung, Gary Chan, Gary C.K. Chan +3 · 9 citations
Medicine · #Cannabis and Cannabinoid Research #Opioid Use Disorder Treatment #Substance Abuse Treatment and Outcomes

paper · doi:10.1016/j.addbeh.2020.106479

openalex publication_date 2020/05/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Citations

• Recall bias in epidemiologic studies
• 2007 National Survey of Mental Health and Wellbeing: Methods and Key Findings
• Time since first cannabis use and 12‐month prevalence of cannabis use disorder among youth and emerging adults in the United States
• New trends in cannabis potency in USA and Europe during the last decade (2008–2017)

Cited by

• Crossed Pathways: Tobacco–Cannabis Co‐Use and Motivation to Quit in Young Adults in France
• A mindfulness-based intervention to reduce altered brain reward function in cannabis use disorder: a double-blind, active and passive, randomised controlled fMRI trial
• Exploring fMRI-neurofeedback to reduce craving-related brain activity in people with cannabis use disorder: A feasibility study
• What Do Thirty Years of Neuroimaging Research Tell Us About Recreational Cannabis Use and Brain Integrity? A Narrative Review of the Multimodal Neuroimaging Evidence to Date
• Who uses legal cannabis and why? Cluster profiles of participants in a Swiss regulated sales pilot trial
• Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023
• No differences in inhibitory control or prefrontal activation during a cannabis cue stop-signal task across CUDIT-R-defined CUD-risk groups
• Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis
• Back on track: Feasibility and efficacy randomized trial of a two-week online self-guided intervention for cannabis use reduction